Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Begum, , Bethany,
DOB: 19-JAN-1976 (Age: 49)
Gender: female
Address:
Studio 22e
Joe unions
M1 Manchester (United Kingdom)
ID: 2365-936148-1 (ECI)
Report
Date: 26-MAR-2021
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Cornbrook Medical Practice
City Road 204
M3 3 Manchester (United Kingdom)
Specimen
Collected: 26-MAR-2021

Chemistry

Test 26-MAR-2021 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 78.6 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.9 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 103.7 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.1 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The only abnormal finding is a mildly elevated HbA1c (6.3%), indicating impaired glucose metabolism or possible prediabetes/early diabetes, despite a normal fasting glucose. All other parameters, including renal function and electrolytes, are within normal limits. Recommend clinical correlation and consideration of further evaluation or lifestyle intervention for glycemic control.